ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Uropharma Limited

Uropharma Limited is an active company incorporated on 25 May 2012 with the registered office located in Norwich, Norfolk. Uropharma Limited was registered 13 years ago.
Status
Active
Active since incorporation
Company No
08083943
Private limited company
Age
13 years
Incorporated 25 May 2012
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 7 June 2025 (6 months ago)
Next confirmation dated 7 June 2026
Due by 21 June 2026 (6 months remaining)
Last change occurred 4 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (9 months remaining)
Address
St Faiths House
Mountergate
Norwich
NR1 1PY
England
Address changed on 4 Sep 2023 (2 years 3 months ago)
Previous address was 2nd Floor, 38-43, Lincoln's Inn Fields, London, WC2A 3PE United Kingdom
Telephone
01603626960
Email
Unreported
People
Officers
6
Shareholders
1
Controllers (PSC)
1
Secretary • Director • British • None
PSC • Director • American • Lives in England • Born in Nov 1949 • Medical Doctor
Director • Solicitor • Irish • Lives in England • Born in Aug 1977
Director • British • Lives in England • Born in May 1958
Director • British • Lives in England • Born in Mar 1980
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Uropharma (UK) Limited
Scott Glickman and Howard Terence Shapland are mutual people.
Active
Uropharma, INC
Scott Glickman and Howard Terence Shapland are mutual people.
Active
Jotillou Enterprises Limited
Scott Glickman is a mutual person.
Active
Viscus Medical Ltd
Scott Glickman is a mutual person.
Active
Secondbridge Holdings Limited
Howard Terence Shapland is a mutual person.
Active
Biovista Sciences Limited
Howard Terence Shapland is a mutual person.
Active
Bioventure Limited
Howard Terence Shapland is a mutual person.
Active
Bioventure Development Limited
Howard Terence Shapland is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2016–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£45.74K
Increased by £1.56K (+4%)
Turnover
Unreported
Same as previous period
Employees
5
Increased by 2 (+67%)
Total Assets
£1.49M
Increased by £131.64K (+10%)
Total Liabilities
-£503.29K
Decreased by £804.15K (-62%)
Net Assets
£987.26K
Increased by £935.79K (+1818%)
Debt Ratio (%)
34%
Decreased by 62.45% (-65%)
Latest Activity
Full Accounts Submitted
1 Month Ago on 17 Oct 2025
Confirmation Submitted
4 Months Ago on 18 Jul 2025
Full Accounts Submitted
1 Year 1 Month Ago on 10 Oct 2024
Confirmation Submitted
1 Year 4 Months Ago on 22 Jul 2024
Mr Andrew Neil Sharkey Appointed
1 Year 10 Months Ago on 1 Feb 2024
Mr Mark Edward Donaldson Appointed
1 Year 10 Months Ago on 1 Feb 2024
Mr Martin O'donoghue Appointed
1 Year 10 Months Ago on 1 Feb 2024
Full Accounts Submitted
1 Year 11 Months Ago on 9 Jan 2024
Registered Address Changed
2 Years 3 Months Ago on 4 Sep 2023
Confirmation Submitted
2 Years 5 Months Ago on 27 Jun 2023
Get Credit Report
Discover Uropharma Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 31 December 2024
Submitted on 17 Oct 2025
Confirmation statement made on 7 June 2025 with updates
Submitted on 18 Jul 2025
Statement of capital following an allotment of shares on 7 November 2024
Submitted on 17 Jul 2025
Appointment of Mr Andrew Neil Sharkey as a director on 1 February 2024
Submitted on 27 May 2025
Appointment of Mr Mark Edward Donaldson as a director on 1 February 2024
Submitted on 27 May 2025
Appointment of Mr Martin O'donoghue as a director on 1 February 2024
Submitted on 27 May 2025
Total exemption full accounts made up to 31 December 2023
Submitted on 10 Oct 2024
Confirmation statement made on 7 June 2024 with updates
Submitted on 22 Jul 2024
Total exemption full accounts made up to 31 December 2022
Submitted on 9 Jan 2024
Statement of capital following an allotment of shares on 9 December 2022
Submitted on 8 Sep 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year